Covered recipient · General Payments record
MICHELLE MARIE RUSHBY
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2024
$1,503.14
- Reported across 87 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $403.54 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $137.93 | 12 |
| Novo Nordisk AS | $72.30 | 3 |
| Acerta Pharma LLC | $49.10 | 3 |
| Astellas Pharma US Inc | $39.25 | 2 |
| Lilly USA, LLC | $35.10 | 2 |
| PFIZER INC. | $28.11 | 2 |
| Amgen Inc. | $24.13 | 1 |
| Otsuka America Pharmaceutical, Inc. | $17.62 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $8.34 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108126025 | CMS |
| ABBVIE INC. | $20.54 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108126027 | CMS |
| ABBVIE INC. | $22.00 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108126029 | CMS |
| ABBVIE INC. | $7.77 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108126031 | CMS |
| ABBVIE INC. | $8.40 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108126033 | CMS |
| ABBVIE INC. | $4.78 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108126035 | CMS |
| ABBVIE INC. | $6.12 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108126037 | CMS |
| ABBVIE INC. | $10.67 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108126039 | CMS |
| ABBVIE INC. | $23.13 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108126041 | CMS |
| ABBVIE INC. | $5.81 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108126043 | CMS |
| ABBVIE INC. | $13.95 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108126045 | CMS |
| ABBVIE INC. | $6.42 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108126047 | CMS |
| Amgen Inc. | $24.13 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117671687 | CMS |
| Astellas Pharma US Inc | $22.72 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139472530 | CMS |
| Astellas Pharma US Inc | $16.53 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139530616 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.52 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104388951 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.21 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105779950 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.37 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105698442 | CMS |
| Lilly USA, LLC | $14.04 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135902122 | CMS |
| Lilly USA, LLC | $21.06 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135836549 | CMS |
| Novo Nordisk Inc | $24.65 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100653319 | CMS |
| Novo Nordisk Inc | $23.54 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100357120 | CMS |
| Novo Nordisk Inc | $24.11 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100452634 | CMS |
| Otsuka America Pharmaceutical, Inc. | $17.62 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119176764 | CMS |
| PFIZER INC. | $13.67 | 04/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131585412 | CMS |
| PFIZER INC. | $14.44 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131684563 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.